Merck said on Wednesday that its experimental oral HIV treatment was not inferior to Gilead's top-selling HIV drug Biktarvy ...

The first gene-editing therapies for HIV/Aids are entering trials but the virus is proving once again that it is a master at ...

Gilead’s investigational drug combo bic/len could help lower the pill burden in patients with virologically suppressed HIV ...

Merck's drug is an antiretroviral treatment, a combination of medicines used to stop the reproduction of the virus.

FINDING COULD CHANGE TREATMENTS. MINDY. DEB, 54. NEWBORNS FROM AROUND THE WORLD RECEIVED ANTIRETROVIRAL THERAPY WITHIN 48 HOURS AFTER THEY WERE BORN, USUALLY, DOCTORS WAIT WEEKS OR EVEN MONTHS AFTER ...

The United States said Tuesday it has delivered a new treatment to prevent HIV in two African countries, months after ...

New study findings could change treatments for HIV in young children. HIV remission may be possible for very young children who begin antiretroviral therapy (ART) hours after birth, according to ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced its upcoming participation in the 20th European AIDS Conference (EACS) to be held in Paris, France from October 15-18. As the leader in HIV ...

Opportunistic infections target people with weakened immune systems, including those with HIV. These conditions can lead to ...

A Q&A With Shauna Applin, ARNP. AJMC: Despite substantial therapeutic advances since the 1980s, the US is not on pace to achieve the goals of the Ending the HIV Epidemic (EHE) public health initiative ...

MEMPHIS, Tenn. - The Memphis area now ranks first in the nation for new HIV infections, according to local health officials. But a global nonprofit is stepping in with a new approach to fight the ...

Integrating tobacco-cessation services into HIV and tuberculosis care can enhance treatment outcomes and reduce mortality. Health systems should implement comprehensive tobacco-cessation strategies, ...